Results 271 to 280 of about 249,813 (313)
Some of the next articles are maybe not open access.
Expert Review of Pharmacoeconomics & Outcomes Research, 2003
Dyslipidemia has been recognized as an important risk-factor for the development of cardiovascular disease. The current, available therapies of dyslipidemia, their effectiveness, costs, cost-effectiveness and healthcare implications are discussed. At the present time, the lipid-lowering therapies are dominated by statins.
Hanna, Zowall, Steven A, Grover
openaire +2 more sources
Dyslipidemia has been recognized as an important risk-factor for the development of cardiovascular disease. The current, available therapies of dyslipidemia, their effectiveness, costs, cost-effectiveness and healthcare implications are discussed. At the present time, the lipid-lowering therapies are dominated by statins.
Hanna, Zowall, Steven A, Grover
openaire +2 more sources
Metabolism, 2014
Diabetic dyslipidemia is characterized by elevated fasting and postprandial triglycerides, low HDL-cholesterol, elevated LDL-cholesterol and the predominance of small dense LDL particles. These lipid changes represent the major link between diabetes and the increased cardiovascular risk of diabetic patients.
Liya, Wu, Klaus G, Parhofer
openaire +2 more sources
Diabetic dyslipidemia is characterized by elevated fasting and postprandial triglycerides, low HDL-cholesterol, elevated LDL-cholesterol and the predominance of small dense LDL particles. These lipid changes represent the major link between diabetes and the increased cardiovascular risk of diabetic patients.
Liya, Wu, Klaus G, Parhofer
openaire +2 more sources
Contraception and dyslipidemia
American Journal of Obstetrics and Gynecology, 1993The risks of cardiovascular disease associated with dyslipidemia differ in women and men, being more strongly associated with triglyceride/high-density lipoprotein in middle-aged women than in men. Although the incidence of heart disease is lower in women because they live longer, over a lifetime, cardiovascular disease in women is equal to that in men,
R H, Knopp, J C, LaRosa, R T, Burkman
openaire +2 more sources
2014
Hyperlipidemia is an important public health problem with increased incidence and prevalence worldwide. Current clinical biomarkers, triglyceride, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol lack the necessary specificity and sensitivity and only increase significantly after serious dyslipidemia ...
Hua, Chen +4 more
openaire +2 more sources
Hyperlipidemia is an important public health problem with increased incidence and prevalence worldwide. Current clinical biomarkers, triglyceride, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol lack the necessary specificity and sensitivity and only increase significantly after serious dyslipidemia ...
Hua, Chen +4 more
openaire +2 more sources
Dyslipidemias and Microcirculation
Current Pharmaceutical Design, 2018Dyslipidemia is widely accepted as one of the major risk factors in cardiovascular disease mainly due to its contribution in the pathogenesis of atherosclerosis in medium-sized and large arteries. However, it has become increasingly accepted that high-cholesterol levels can also adversely affect the microvasculature prior to the development of overt ...
Teresa, Padró +2 more
openaire +2 more sources
Pharmacotherapy of Dyslipidemia
Cardiovascular Drugs and Therapy, 2001Reducing elevated levels of low-density-lipoprotein cholesterol (LDL-C) significantly reduces the incidence of coronary heart disease (CHD) events and mortality in hypercholesterolemic patients. CHD risk reduction is proportional to LDL-C reduction. Despite this knowledge, many physicians are not applying existing treatment guidelines to the extent ...
openaire +2 more sources
Endocrinology and Metabolism Clinics of North America, 2003
The primary dyslipidemia related to obesity is characterized by increased triglycerides, decreased HDL levels, and abnormal LDL composition. Much work has been done to elucidate the pathogenesis of the dyslipidemia of obesity, which seems to be closely related to insulin resistance in obese individuals; however, more studies in humans are needed to ...
Barbara V, Howard +2 more
openaire +2 more sources
The primary dyslipidemia related to obesity is characterized by increased triglycerides, decreased HDL levels, and abnormal LDL composition. Much work has been done to elucidate the pathogenesis of the dyslipidemia of obesity, which seems to be closely related to insulin resistance in obese individuals; however, more studies in humans are needed to ...
Barbara V, Howard +2 more
openaire +2 more sources
Endocrine Practice, 1996
To summarize recommended treatment strategies for various dyslipidemias.The basic pathways of lipoprotein metabolism are reviewed, and the potential for interventional alterations to correct specific dyslipidemias is outlined. Guidelines for treatment based on published clinical trials, including the consensus report of the National Cholesterol ...
openaire +2 more sources
To summarize recommended treatment strategies for various dyslipidemias.The basic pathways of lipoprotein metabolism are reviewed, and the potential for interventional alterations to correct specific dyslipidemias is outlined. Guidelines for treatment based on published clinical trials, including the consensus report of the National Cholesterol ...
openaire +2 more sources
Continuum, 2011
: Numerous studies have been conducted in the past decade evaluating the use of statins and other lipid therapies for reducing vascular events. These studies have impacted the area of stroke prevention.: For patients with established coronary artery disease, statins reduce the rate of stroke. High-dose statin treatment has also been found to reduce the
Pratik, Bhattacharya +1 more
openaire +2 more sources
: Numerous studies have been conducted in the past decade evaluating the use of statins and other lipid therapies for reducing vascular events. These studies have impacted the area of stroke prevention.: For patients with established coronary artery disease, statins reduce the rate of stroke. High-dose statin treatment has also been found to reduce the
Pratik, Bhattacharya +1 more
openaire +2 more sources
Heart Disease, 2002
Dyslipidemia is recognized as a significant risk factor for atherosclerotic disease. There has been a great deal of progress in the detection and management of dyslipidemia, but challenges remain, including whether to treat children, adolescents, and the elderly.
openaire +2 more sources
Dyslipidemia is recognized as a significant risk factor for atherosclerotic disease. There has been a great deal of progress in the detection and management of dyslipidemia, but challenges remain, including whether to treat children, adolescents, and the elderly.
openaire +2 more sources